• 1962 Finished post-doctoral school at the University of Tokyo with the degree of Ph.D. • 1962 Appointed to be an instructor in Physiology, the University of Tokyo Medical School. • 1965 Research Associate at Columbia University, New York. • 1966 Visiting scientist at the National Institutes of Health • 1973 Professor and Chairman in the Department of Physiology, Teikyo University Medical School • 1996- 2006 Chairman of Muscle Committee in the International Union of Physiological Sciences (IUPS) • 2004 Retired from Teikyu University with the title of Emeritus Professor

Physiological science, Nanoscience, Nanotechnology

Professor Chul Soon Yong graduated from the College of Pharmacy, Seoul National University in 1980 and completed his master’s degree in the same university in Department of Pharmaceutics. On receiving his PhD degree from the University of South Carolina in 1991, he joined the College of Pharmacy, Yeungnam University and served as the dean in 2009. He was president of The Korean Society of Pharmaceutical Sciences and Technology, president of The Asian Federation for Pharmaceutical Sciences (AFPS), vice-president of The Pharmaceutical Society of Korea, chair of Organizing Committee for AFPS Conference 2013 and vice-chairman of The Local Organizing Committee of FIP Seoul Congress 2017. Professor Yong has published around 300 papers in SCI journal and around 90 publications in Korean Journals, and edited several books.

His research interests cover the development of novel drug delivery systems and have expanded to include the application of various nanoparticles in drug delivery to treat cancers. He has been supervised more than 85 M.S. and 36 Ph.D. scientists in his academic carrier.

Meser M. Ali received his Ph.D. degree in Organometallic Chemistry from Mie University in Japan in 1999. He is an Associate Scientist in the Department of Neurosurgery, and Director, Cellular and Molecular Imaging laboratory, Henry Ford Hospital, Detroit, Michigan, USA. He is also an Associate Professor (adjunct) in the Department of Chemical Engineering and Material Science, Wayne State University, Detroit, Michigan, USA. His research program focuses on the development of small-sized nanomedicine that can cross tumor blood brain barrier for potential applications of brain cancer imaging and therapy. His research program has been supported by National Institutes of Health (NIH).

My research interest is in the discipline of nanomedicine and drug delivery with noninvasive molecular imaging. Nanomedicine, carrying therapeutic payloads and delivered within close proximity of the tumor, can be designed to play a significant role in increasing treatment effectiveness while decreasing severity of side effects. Specifically, my research work focuses in developing small-sized nanoparticles that can cross tumor blood brain barrier and target primary glioblastoma multiform (GBM) selectively. My work resulted in the development of a series of new dendrimer-based multifunctional nanoparticles that are detected by standard MR relativity methods or new MRI methods based on Paramagnetic Chemical Exchange Saturation Transfer (PARACEST). My developments of small nano-sized molecular imaging agents that can target GBM selectively. Therefore, primary GBM tumor selective drug delivery and imaging can be accomplished by using these dendrimer-based nanoparticles that possess long blood half-lives. We have reformulated promising anti-cancer drugs that failed to reach clinical trials, or failed in clinical trials due to toxicity or poor bioavailability. These reformulations have reproduced usable, safe therapies using nanoparticles. I have also used state-of-the-art MRI methods to study tumor progression and the early responses to chemotherapies in pre-clinical animal models.

Since 2011, Dr Li has worked in the field of nanotechnology and targeted delivery for chemotherapy. She has rationally designed functional nanoparticles (layered double hydroxide, nanoemulsion, silica and QDs) as nanocarriers to deliver drugs and siRNAs into cancer cells to efficiently kill the cancer cells. Meanwhile, she has developed the strategy to co-deliver drugs and gene in LDH nanoparticles to improve efficiency of treatment. Recently, the receptor conjugated nanoplatforms (nanoclay and nanoemulsion, etc) have been developed by nano-engineering approach to efficiently deliver drugs and siRNA to specific organs for the treatment of cancer and animal disease. She has established a solid platform for the delivery of inorganic nanoparticles into various mammalian cells in terms of the research experience and methodology.

Currently, her research focuses on design and engineering functional nanomaterials for drug/gene delivery, sustainable release and oral vaccine delivery for human health and animal health management including the following directions: 1) Engineering nanomaterials (layered double hydroxide, silica and solid lipid nanoparticles, etc) as nanocarriers for therapeutic drug/ siRNA delivery in cancer therapy 2) Surface modification of nanomaterials for biomedical applications 3) Development a simple and cost-effective platform technology for antimicrobial drug delivery and sustainable release to improve animal health

Dr. Chandra P. Sharma is former Senior Scientist G and Head, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum and has been Head, Biosurface Technology Division, SCTIMST, Trivandrum from January 1980 to February 2014. He has also been Associate Head, Biomedical Technology Wing, and Associate Dean, PhD Affairs, SCTIMST Trivandrum. Presently he is Adjunct Professor, Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, and Hon. Emeritus Professor, College of Biomedical Engineering & Applied Sciences, Purbanchal University, Kathmandu, Nepal.Dr Sharma has been TMI/DTM of COFRAC accredited Quality System ISO 17025 for over a decade. He is basically a Solid State Physicist from IIT Delhi and received his training in Biomaterials area in the University of Utah (USA) with Prof. D.J. Lyman as a graduate student and in the University of Liverpool, England with Prof. D.F. Williams as a Post Doctoral Research Associate. Dr. Sharma has been awarded FBSE (Fellow Biomaterials Science & Engineering) by The International Union of Societies for Biomaterials Science & Engineering (IUS-BSE) in 2008 and FBAO (Fellow Biomaterials and Artificial Organs) by Society for Biomaterials & Artificial Organs (India) (SBAOI) in 2011. He is member of, Steering Committee of the International College of Fellows (2012-16) and IUS-BSE (2003 onwards). He has been recognized with various awards and honors such as MRSI medal (1994) and MRSI-ICSC Superconductivity & Materials Science Annual Prize Award 2009 – Materials Research Society of India, Distinguished Scientist award – Society for Biomaterials and Artificial Organs, India (SBAOI) and shares Whitaker and National Science Foundation Award – International Society for Artificial Organs (ISAO) USA,invited member ACS(2015-2018).

Biomaterials and Medical Products Commercialization,Nanotechnology,Polymers,Protein and Cells at Interfaces,Surface Characterization and Modification,Tissue Engineering,Cardiovascular Biomaterials,Biomaterials Education,Ceramics,Drug Delivery

Dianping Tang, Full Professor for Analytical Chemistry at the Fuzhou University, China, was born in 1972. He received the diploma degree in biochemistry from Sichuan Three Gorges University of China in 1986, and PhD from the Southwest University of China in 2008. His research interests mainly include Clinical/Environmental immunoassays, Biological and Chemical microsensors, Synthesis and application of advanced functional nanomaterials, Fabrication of microfluidic device. At present, projects are focused on two areas: (i) Synthesis of advanced functional nanomaterials and application in biological and chemical microsensors, (ii) design and fabrication of a new family of immunoassays based on micro- and nanofluidic devices. The detection methods mainly consist of electrochemistry, surface plasma resonance (SPR), quartz crystal microbalance (QCM) techniques and immunoaffinity chromatography. He received the Alexander von Humboldt Fellowship in 2008, and worked Technische Universitat Munchen, Germany, from 2008 to 2009. Importantly, he was selected amongst the 100 most influential People in the Analytical Scientist in 2013. He is currently a member within the editorial board of “Analytical Chemistry”, “Scientific Reports” and “Microchimica Acta”. Up to now, more than 100 publications under his authorship appeared in reviewed international scientific journals.

Clinical/Environmental immunoassays; Biological and Chemical microsensors; Advanced functional nanomaterials; Fabrication of microfluidic device

Prof. Erhan Pişkin was graduated from Ankara University, Chemical Engineering Department in 1970, and joined Hacettepe University, Chemical Engineering Department. He completed his PhD in January 1976 at Hacettepe University, became and Associated Professor in 1981 and then a Full Professor in 1988. He is still working in the same departments, and chair Chemical Technology Division. He is the founder of “Bioengineering Graduate Program” as a Division at Institute of Science, Hacettepe University, and chair the Bioengineering Division now. He is the founder of Biyomedtek: Biomedical Technologies which was founded as a Turkish Scientific and Technological Council: Academia-Industry Collaborative Research Center, which was then converted into a Society and its Economical Enterprise. He is chairing the Management Committees of both. He was a Member of “Science Board” of Turkish Scientific and Technological Council for about 9 years (2000-2009). His awards include TÜBİTAK-Junior Scientist Award (1981); C.P.Sharma International Award in Biomedical Engineering (1997); Hacettepe University-Science Award (1999); and TÜBİTAK-Science Award (2000). He has about 362 scientific papers in internationally cited journals + about 20 chapters in books + more than 250 presentations in international and national meetings + editor/author of 10 Books (6 in English and 4 in Turkish). His citations are close to 6000 with an HI index of a 41. He has supervised more than 50 PhD and 100 MSc theses in the last 30 years. He has organized about 20 International and Several National meetings in Turkey.

His main research interests are: polymers: synthesis and use in diverse fields, mostly as biomaterials (biodegradable) and Tissue Engineering and Regenerative Medicine (recently with stem cells); gene transfer with nonviral polymeric vectors; Nanoparticles and structures for biosensors EIS, SEFS, SERS, MALDI-TOF, etc. and array technologies recently for detection of pathogenic bacteria using bacteriophages; bioaffinity separation, diagnostic test kits and drug delivery based on polymeric carriers.

Education and work experience: Giuseppe De Rosa graduated in 1997 in Pharmaceutical Chemistry and Technology at the University of Napoli Federico II. In 2001 he completed a Ph.D. in Pharmaceutical Technology with a dissertation with the title “Delivery of biotechnological drugs by biodegradable microspheres”, with research activity carried out in part at the University Paris-Sud of Chatenay-Malabry (France). From 1999 to 2002, he carried out research activity at the University Paris-Sud of Chatenay-Malabry (France). From 2002 Dr De Rosa was assistant professor at the Faculty of Pharmacy – University of Naples Federico II. From 2014, Dr De Rosa is associate professor at the Department of Pharmacy, University of Naples Federico II. In the same year, he received the national scientific qualification as full professor. Scientific activity: The scientific activity of Dr De Rosa can be summarized as design and development of drug delivery systems based on micro- and nanotechnologies. More in detail, the research activity is focused on the development of liposomes and other lipid-based nanovectors (e.g. self-assembling nanoparticles) for delivery of drugs especially designed for systemic or topical administration; polymeric particles for sustained release of drugs; semisolid formulations for topical administration of drugs. Dr De Rosa is author of about 80 papers on international journals, 4 book chapters and different patent applications (with granted PCT, US and EU patent). On product developed by G. De Rosa received the orphan designation by European Medicine Agency in august 2016. For his research activity, Dr De Rosa received different financial support, among them one by MIUR (Italian Minister for the University and Research) and Ministero della Salute (Italian Minister of Health).

Dr De Rosa is Editor in Chief of International Journal of Medical Nano Research and member of the Editorial Board of different journals in the field of drug delivery; he was Lead Guest Editor for Journal of Drug Delivery co-Guest Editor for Journal of Amino Acids. He also collaborates as referee with different international journals of pharmaceutical technology. Dr De Rosa received different awards, among them two awards by the Italian association of pharmaceutical industry (Associazione Farmaceutici Industria or AFI) for the best presented work during the Annual Symposyium AFI in June 2011 and 2013, respectively. Dr De Rosa is member of the Board ADRITELF Italy Chapter, member of the Board of the Controlled Release Society (CRS), and member of other scientific associations or research centers.

1. Development of Experimental Scientific Research in Faculty of Medicine, Mansoura University 2. Raise awareness of the importance of empirical research among students, alumni, faculty members and their assistants 3. Opening up the work of scientific research cooperation between the University of Mansoura, universities and scientific research centers, homeland 4. Scientific cooperation with the international scientific centers 5. The events of integration and compatibility between the basic research disciplines and interdisciplinary clinical Faculty of Medicine, Mansoura University 6. Activating the empirical research university and marketing adopted after the research projects with a national moving implementation of the protocols of interest to the university research 7. The implementation of workshops for the departments of clinical use of experimental animals 8. Implementation of local training courses and international empirical research for young researchers

cancer stem cell, and its targeting using different approach

Farahnaz Barahuie received her PhD degree in Nanosciences from Institute of Advanced Technology, University Putra Malaysia in 2015. She joined the University of Sistan and Baluchestan in 2016, where she is currently an Assistant Professor. Her research is focused on using various nanoparticles (metal, metal oxide, polymer and carbon materials) and nanocomposites for drug and gen delivery and sensing applications, Nanoenergy and nanomaterials for carbon dioxide capture.

1. Drug delivery and biosensing application of layered double hydroxide, layered hydroxide, graphene, graphene oxide, activated carbon, fullerene, CNT, various metal and metal oxide nanoparticles, chitosan, liposome, polyethylene glycol etc. Key interests are nanomedcience in particularly drug and gen delivery, bioimaging and biosensing for theranostic applications 2. Tissue engineering 3. Nanoenergy 4. Nanomaterials for carbon dioxide capture 5. Water treatment

1. Jul. 2017 – Present, Full Professor in Department of Chemistry, Fuzhou University; 2. Sep. 2011 –Jun. 2017, Associate Professor in Department of Chemistry, Fuzhou University; 3. Apr. 2009 – Aug. 2011, postdoctoral research fellow in Prof. Dong-Hwan Kim’s BioSurface Engineering Lab, School of Chemical and Biomedical engineering, Nanyang Technological University; 4. Sep. 2004 – Apr. 2009, Ph. D candidate in Prof. Guonan Chen’s Ministry of Education Key Laboratory of Analysis and Detection for Food Safety.

 Localized surface plasmon resonance (LSPR) biosensors;  Surface-Enhanced Raman Scattering (SERS) based analytical devices;  Chemiluminescent and electrochemiluminescent based nanomaterials;  Nano-optical based modern separation.

Dr. Kaiyong Cai is a Professor in biomaterials and nanomedicine. He received his Ph.D. degree in Biomedical Engineering from Tianjin University in 2002. He is a distinguished Professor of Cheung Kong Scholars. He was awarded China Youth Science & Technology Award in 2011. His research interests include biointerfeces of biomaterials and controlled drug delivery system. He has published more than 150 articles in peer-reviewed international journals with over 3800 citations. He is editorial board member of journals such as Frontiers of Materials Science, World Journal of Stem Cells, AIMS Materials Science. He is also an ad-hoc reviewer for more than 60 international journals such as Chem Soc Rev, J Am Chem Soc, Adv Mater, Angew Chem Int Edit, Nano Lett, Biomaterials, ACS Nano, Small et al.

His research interests include biointerfeces of biomaterials and controlled drug delivery system.

Jian-Hui Jiang obtained his Ph.D. degree in analytical chemistry from Hunan University in 1999, and began his academic career at the same university. He had a postdoctoral and a visiting professor fellowship at Kwansei Gakuin University in 2001 and 2003. He has become a full professor at College of Chemistry & Chemical Engineering of Hunan University since 2003. His research interest includes bioanalytical chemistry, biosensors and chemometrics. He has accumulated over 300 peer-reviewed research publications with H index of 55 and over 11,000 citations, and won honors including Outstanding Young Scientists Funding of NSFC, Young and Middle-Aged Leading Scientists, Engineers and Innovators by Ministry of Science and Technology of China, RSC Fellow, and National Natural Science Award.

His research interest includes bioanalytical chemistry, biosensors and chemometrics.

1991.9-1995.7 Bachelor degree in Mineral Process Engineering, China University of Mining and Technology, Beijing, China  1995.8-1999.8 Engineer, Xiayukou Coal Washery in Hancheng Mining Bureau, Xi'an, Shaanxi, China  1999.9-2002.4 Master degree in Materials Processing and Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, China  2002.5-2005.7 Ph.D. in Materials Science, Northwestern Polytechnical University, Xi'an, Shaanxi, China  2005.9-2007.8 Post-doctoral research associate, Aeronautical and Astronautically Science and Technology, Northwestern Polytechnical University, Xi'an, Shaanxi, China  2007.4-2013.3 Associate Professor, Institute of Biomedical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, China  2013.4- today Professor and Head of Institute of Biomedical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, China

 3D bioprinting.  Design the bio-polymer. Structuring and synthesizing the biodegradable polymers for bone tissue engineering and biomembrane application.  Novel drug delivery system, including the fabrication of liposome, microspheres and intralipid based vehicles.

Dr. Jianmin Qin is Professor of the third hospital affiliated to Second Military Medical University. He has over 20 years of experience in the research, discovery and business development of medications aimed to treat the hepatocellular carcinoma. Previously, Dr. Jianmin Qin served as the Head of hepatobiliary surgery at Shanghai University of Traditional Chinese Medicine. During his career at the two university, Dr. Jianmin Qin holds a Ph.D. and M.D. in Hepatobiliary Surgery from institute of liver cancer affiliated to Second Military Medical University. Notably, Dr. Jianmin Qin has authored more than 120 manuscripts, 6 patents, and co-edited "Targeted drug therapy for hepatocellular carcinoma".Dr. Jianmin Qin is also an adjunct faculty member a Shanghai University of Traditional Chinese Medicine in Shanghai where he teaches " Precise tumor therapy ", a class focused on the therapy and prevention of malignant tumors.

" Precise tumor therapy ", a class focused on the therapy and prevention of malignant tumors.

Dr. Mohanad Naji Sahib received his B.S. in Pharmaceutical Sciences and MSc. in Pharmaceutics from College of Pharmacy, Baghdad University, Baghdad, Iraq in 1999 and 2006, respectively. He received his Ph.D. degree in Pharmaceutical Technology from School of Pharmaceutical Sciences, Universiti Sains Malaysia in 2012. He was formerly worked as an assistant professor at Universiti Sains Malaysia and currently he is a lecturer in the Faculty of Pharmacy, Al-Rafidain University College, Baghdad, Iraq. Dr.Mohanad is a member of the Editorial Board for American Journal of Nanomaterials, a member in the International Society for Aerosol in Medicine and a member in the scientific board for Al-Rafidain University College.

His interdisciplinary research focuses on formulation and characterization of nanoparticles as a delivery system especially for pulmonary system. Other major interests are pharmacy practice, quality of life and management of chronic diseases.

Magdalena Stevanovic, Principal Research Fellow at Institute of Technical Sciences of the Serbian Academy of Sciences and Arts, was born on August 04, 1974 in Belgrade, Serbia. She took her PhD degree in Materials Science from the Faculty of Physical Chemistry in Belgrade in December 2007 (PhD best thesis award by the Materials Research Society of Serbia, 2008). The fields of expertise covered by the thesis are nanotechnology, controlled delivery of drugs, biomaterials and polymers. She is a Vice President of the Organizing and Scientific Committee of Young Researchers Conferences "Science and Engineering of New Materials" since 2013 and also was a member of the organizing committees of several international conferences. Board member of the Association of the Scientific Institutes of Serbia for Technological and Biotechnical Sciences since December 2011.

Biomedical Engineering, Nanomaterials, Controlled Drug Delivery, Biomaterials, Nanomedicine, Tissue engineering, Nanotoxicity

Honors and Awards : National researcher recognized by the National Council of Science and Technology of Mexico (CONACYT-Mex.). Pharmapeptides prize to the best doctoral thesis (France, 1998). CANIFARMA prize to the best technological development in pharmaceutical sciences for veterinarian (2011) and human (2013, 2015).

Therapeutic nanotechnology. Development of new techniques to prepare nanoparticulate systems (nanospheres, nanocapsules, latexes, etc.). Design and evaluation of new strategies to increase the bioavailability of lipophilic drugs.

Dr. Ahad Mokhtarzadeh is the holder of a PhD awarded to him by the Department of pharmaceutical biotechnology at Mashed university of medical science, Iran. Currently, he is working as an Assistant Professor in the Immunology Research center at Tabriz University of Medical Sciences, Iran. His fields of interests are research in Cancer Research, nanoparticle based gene/drug delivery systems and development of biosensors for detection of different analyte especially cancer biomarkers.

Drug/ gene delivery by nanoparticles, Nano biosensors

Dr Sen is an expert in nano chemistry and nano-biomaterials with more than 20 years research experience from laboratory scale development to commercial products. He is the principal inventor of PCT application for three Great Britain patents and has published more than 50 high impact peer review journal articles of his original work, two high impact review articles, two book chapters and seven articles in books in the area of nano-biomaterials chemistry. He managed several international research projects as a principle investigator in the past. He has successfully delivered two International workshops. One in August 2015 (https://nanowateratuclan.org/an-international-workshop-on-magnetic-nanoparticles/) and one in January 2018 (https://uclannanomedicine.net/news-highlight/). He has also coordinated one international symposium “Functional Nanomaterials in Industrial Applications: Academic-Industry Meet” in March 2016 (www.nanosymposiumatuclan.net) as a chair.

His research mostly on Functional Nano and Nano-biomaterials in the applications in environmental cleaning, Nanomedicine especially in drug delivery and cellular imaging, Green chemistry and industrial catalysis. He is currently coordinating two important multinational projects in collaboration with academic and Industrial organisations around the world. More information about one of the on-going projects on Nanomedicine can be found in www.uclannanomedicine.net where he has recently delivered an International workshop in January 2018. His current research is now available to view via Youtube (https://www.youtube.com/watch?v=ePLauSsqvdM&feature=youtu.be).

1. Presently Working as Assistant Professor of Chemistry at Jamia Hamdard University from 6th Dec 2006. 2. Worked as Lecturer (ad-hoc) of Chemistry at Shaheed College Rajguru of Applied Sciences (Delhi University) from 17th July 2006 to 5thDec 2006. 3. Worked as ad-hoc Lecturer at S.G.T.B Khalsa college (Delhi university) from 21st july 2005 to 30th April 4. Worked as guest Lecturer at Chemistry at Shaheed Rajguru College of Applied Sciences (Delhi University) from 17th July 2004 to 17th July 2006

I wish to introduce myself, I am Rajasekharreddy Pala working as a post-doctoral research fellow with Prof. Nauli in the Department of Biomedical and Pharmaceutical Sciences Department, and Department of Medicine, University of California Irvine. I am very much interested to be a join as a editorial board member of your Journals “Advances in Nanomedicine and Nanotechnology Research, BioMed Research and Journal of Drug Design and Discovery Research”. Currently, we are working on nanoparticle-based drug delivery to cancers and hypertension. We are using drug delivery agents as nanoparticles (polymeric and magnetic) as well as targeting antibodies and peptides to achieve site-specific actions. I have earned my Ph.D. in July 2014 from Indian Institute of Chemical Technology, India, under the guidance of prof. Usah Rani. During my Ph.D. and Postdoctoral research, I have acquired profound experience in the areas of nanoparticles synthesis, characterization, protein-lipid-nanoparticles (core-shell type) in vivo antimicrobial activity, drug delivery to tumors, targeted delivery of drugs to cardiomyocytes. My achievements during Ph.D. include the development of antimicrobial peptide-coated nanoparticles for the treatment of S. aureus infection in vivo preclinical models. The achievements during my postdoctoral research include preparation of an efficient drug delivery systems for the treatment of vascular hypertension.

With the deep experience in nanoparticles synthesis, characterizations, biological applications, development of drugs for cancers, cardiovascular diseases.

Dr. Serap Yalçın is currently working as an Associate Professor in the Faculty of Molecular Biology and Genetics, Kırşehir Ahi Evran University, Turkey. She received her M.S. and Ph.D. degree from Forensic Science Institute, Ankara University. She completed her postdoctoral training at Department of Biological Sciences, Middle East Technical University and Klinikum rechts der Isar, Technische Universitat Müchen.

Her research is focused on cancer molecular biology, targeted drug delivery in cancer, molecular docking and molecular dynamics simulation.

Qualifications: BSc,MSc and PhD of organic chemistry–university of Khartoum -faculty of science-department of chemistry. Duties: Teaching general chemistry for faculties of science ,pharmacy ,laboratories and medicine. Teaching organic chemistry for faculty of science and pharmacy. Supervising graduation dissertations, MSc and PhD thesis. Publications: 5 papers in well-known science journals. Training periods: 16 periods mostly performed in Ahfad University for Women( AUW)–Sudan and American University (AUB)–Beirut.

Dr. Prakash Prajapat is presently working as Assistant Professor in Chemistry Department, Mehsana Urban Institute of Sciences, Ganpat University, INDIA. He received his M.Sc. degree in (Org. Chem.) and his Ph.D. degree under the supervision of Prof. Ganpat L. Talesara from Mohanlal Sukhadia University, Udaipur (INDIA). He was a recipient of JRF and SRF from UGC, New Delhi and qualified CSIR-NET, SET & GATE exams. He has published 28 research articles in various reputed national and international journals. He has also participated in 25 national and international conferences/symposia/workshops. His research interests include “Drug design, Synthesis of novel heterocyclic hybrids and their pharmacological assay”. In addition, He is currently life fellow member of Indian Society of Chemists and Biologists (ISCB), Indian Chemical Society (ICS), Indian Council of Chemists (ICC) and also Bentham Brand Ambassador for Bentham Science Publishers. Dr. Prajapat is currently member of 35 advisory boards and reviewer of many peer-reviewed prestigious national and international journals and reviewed more than 48 research and review articles.

Organic Synthesis, Catalysis, Heterocyclic Chemistry, Green Chemistry, Medicinal Chemistry, Pharmacological Assay.

Dr. Zorawar Singh is working in the field of Genetic Toxicology and Occupational Health. Dr. Singh is a life member of Society for Environment and Conservation (Regd.), Punjab, India and Indian Association of Nuclear Chemists and Allied Scientists, BARC, India. He is a former member of Punjab Eco Friendly Association. He has completed two research projects granted by University Grants Commission, India and Punjab State Council for Science and Technology, Chandigarh in collaboration with Department of Science and Technology (DST) and National Council for Science and Technology Communication (NCSTC), Government of India and is currently working on third one. He has reviewed more than 40 research papers for different conferences and for more than 10 International journals including Chemico-Biological Interactions, Toxicology and Industrial Health, Iranian Journal of Public Health, Human and Experimental Toxicology, International Research Journal of Public and Environmental Health and Walailak Journal of Science and Technology, Thailand. He has published more than 40 research papers in different National and International journals in the field of toxicology and health

Andrey Nikolaevych Belousov graduate from Kharkov Medical Institute in 1988. Doctor of Medicine degree on speciality - An¬esthesiology and Intensive Care since 2004. The title dissertation: “Extracorporal hemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales dis¬eases”. Author a new medecine products – nanotechnology preparations based on magnetite nanoparticles (Fe3O4) of the size 6-12 nm (www.nanolab.com.ua): the peroral form - Micromage-B (the biologically active additive officially registration in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application – ICNB (intracorporal nanosorbent). A.N. Belousov is author new method of extracorporal hemocorrection using magnet-controlled sor¬bent (MCS-B).

Nanomedicine, Intensive Care, An¬esthesiology, Transfusiology.

Dr. Magdy Ali is a manager of the Method Development And Validation Department at European Egyptian Pharmaceutical Industries. He received a Ph.D. in Materials science (Quantum dots) from Institute of Graduate Studies and Research (IGSR), Alexandria university in Egypt. He participated to the Visiting Scientist Program (VSP) at USP for nine months since October 2013. He has over 20 years of experience in QC, stability study programs, and method developing and validation.

Department of Materials Science

Pursue a proven academician in Physics by imparting my skills and enthusiasm to bring up an involved society of students in the light of Science.

University of Padova (Italy) (A. Y. 2018-2019) School of Engineering & School of Medicine Adjunct Professor of: “Physics and Informatics” (in charge) “Chemistry, Physics and Statistics” (in charge) “Informatics” (in charge) “Physics 1” (in charge - Laboratory part)

- Theoretical Physics, Mathematical Physics, Transdisciplinary Physics - Classical & Quantum Relativistic Nanophysics, Nano-bio-technology, Modern Solid State Physics, Nano-Neuroscience - Theories of Everything, Foundations of Physics, Metaphysics, Quantum Consciousness - History and Philosophy of Science, Science Education

(i) UGC-CSIR-NET(JRF) qualified in 1999. (ii) Received CSIR-JRF(NET) from July 01, 2000 to June 30, 2002. (iii) Received CSIR-SRF(NET) from July 01, 2002 to Nov. 14, 2002. (iv) Received University Merit Fellowship of G.B. Pant University of Ag. & Tech., Pantnagar from July 27, 1999 to June 30, 2000. (v) Received Graduate Teaching Assistantship of G.B. Pant University of Ag. & Tech., Pantnagar from Jan 15, 1998 to May 17, 1999. (vi) Received Akikrit Scholarship, U.P. during 1987-89.

Theoretical Condensed Matter Physics, High Tc- Superconductivity, Nanomaterials, Material Science, Science Education, Science Popularization

A self-motivated, electrochemist possessing 9 years of extensive experience in the electrochemical deposition of base metals, 6 years of experience in the electrochemical corrosion study of Pb free solder alloys, steels, cathodic protection of metals at universities in Taiwan , Finland and Western Australia.

Multimetallic nanopowders, silver nanowires, electroplating, Corrosion of Pb free solders, green synthesis of nanoparticles

 Prof. Farzad Kobarfard ( Department of pharmaceutical chemistry, Shahid beheshti university of medical sciences, Tehran. Iran.)  Prof. Mahmoud Jeddi Tehrani(Avicenna Research Institute, Tehran, Iran.)  Prof. Alireza Foroumadi (Department of pharmaceutical chemistry,Tehran university of medical sciences, Tehran, Iran.)  Prof. H.Rabbani (Avicenna Research Institute, Antigen-antibody research center, Tehran, Iran.)  Dr.Mahdi Shabani(Shahid beheshti university of medical sciences, Department of immunology,Tehran, Iran.)

 The role of magnetic quantum dots in drug delivery.  Nanostructures in biosensors.  Nanomaterials in drug delivery, Application and characterization.

I am a nanotechnology scientist and I’ve got a Phd in this field. with expertise in Nano materials and nano composites.. I hope to be suitably qualified as an editor in order to have further cooperation with you and also play a prominent role in your journal.

Nanomedicine & and Nanotechnology